“…In in vitro studies, mefloquine has been shown to interact with a number of potential neurological targets, including neuronal calcium homeostasis, the endoplasmic reticulum calcium pump, acetylcholinesterase, blood-brain barrier P glycoproteins, glutaminergic synaptic activity, connexins, A 2 a receptors, and potassium and anion channels (6,8,16,17,21,22,24,30,44). The A 2 a receptor is a strong candidate for potential involvement, given its suspected role in sleep modulation and its potent inhibition by mefloquine (41,42,44).…”